Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme (Q33343042)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme |
scientific article |
Statements
1 reference
Multicentre phase II and pharmacokinetic study of RFS2000 (9-nitro-camptothecin) administered orally 5 days a week in patients with glioblastoma multiforme (English)
1 reference
E Raymond
1 reference
M Campone
1 reference
R Stupp
1 reference
J Menten
1 reference
P Chollet
1 reference
T Lesimple
1 reference
R Fety-Deporte
1 reference
D Lacombe
1 reference
X Paoletti
1 reference
P Fumoleau
1 reference
EORTC Early Clinical Studies Group (ECSG)
1 reference
Brain Tumor Studies Group (BTSG)
1 reference
New Drug Development Program (NDDP)
1 reference
1 July 2002
1 reference
1 reference
38
1 reference
10
1 reference
1348-1350
1 reference
Identifiers
1 reference
1 reference